東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

NAFLD Surveillance in the Alaska Nat...

Rhodes, Wileina Saumara,

FindBook

Google Book

Amazon

博客來

NAFLD Surveillance in the Alaska Native/American Indian Population /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	NAFLD Surveillance in the Alaska Native/American Indian Population // Wileina Saumara Rhodes.
作者:	Rhodes, Wileina Saumara,
面頁冊數:	1 electronic resource (125 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: A.
Contained By:	Dissertations Abstracts International86-12A.
標題:	Epidemiology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32113731
ISBN:	9798280755512

NAFLD Surveillance in the Alaska Native/American Indian Population /
Rhodes, Wileina Saumara,

NAFLD Surveillance in the Alaska Native/American Indian Population /Wileina Saumara Rhodes. - 1 electronic resource (125 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: A.

In the United States, the prevalence of NAFLD is estimated at 24% of the population, and by 2030, the incidence of NAFLD will increase to 100.9 million cases. This study aimed to determine the prevalence and rate of non-alcoholic fatty liver disease (NAFLD) progression in the Alaska Native/ American Indian population (AN/AI) with and without elevated liver function tests. Two research questions guided the study: Do outcomes (abnormal/normal) of LFTs, A1C, lipids, BMI, and inflammatory markers predict or have a relationship with NAFLD progression? Does NAFLD surveillance have a relationship with the patient's outcome as measured by the NAFLD Fibrosis score and FibroScan CAP Score? The theoretical approaches to this study were the transtheoretical model and the health belief model. A quantitative correlational design was used, requiring a minimum sample size of at least 92 participants. Secondary data were obtained from the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program database. The inclusion criteria of the study were AN/AI patients with NAFLD. The results of the study indicated that ALT, AST, and Steatohepatitis were significant predictors of NAFLD Fibrosis score. An increase in A1C, triglycerides, and BMI corresponded with an increase in CAP Scores, while an abnormal AST level corresponded to a decrease in CAP Scores. Plasma ALT evaluation resulted in a decrease in NALFD incidence rates. Various organizations may adopt these study findings to help them in formulating guidelines that will help them in educating the members of the public on risk factors of NAFLD, as well as advocate for appropriate mechanisms in mitigating them. .

English

ISBN: 9798280755512Subjects--Topical Terms:

568544
Epidemiology.
Subjects--Index Terms:

Non-alcoholic fatty liver disease

NAFLD Surveillance in the Alaska Native/American Indian Population /
LDR:03156nmm a22004573i 4500 001 2437573
005 20251124054807.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798280755512
035 $a (MiAaPQD)AAI32113731
035 $a AAI32113731
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Rhodes, Wileina Saumara, $e author. $3 3828609
245 1 0 $a NAFLD Surveillance in the Alaska Native/American Indian Population / $c Wileina Saumara Rhodes.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (125 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: A.
500 $a Advisors: Mori, Naoyo; Miller, Leah.
502 $b Ph.D. $c Walden University $d 2025.
520 $a In the United States, the prevalence of NAFLD is estimated at 24% of the population, and by 2030, the incidence of NAFLD will increase to 100.9 million cases. This study aimed to determine the prevalence and rate of non-alcoholic fatty liver disease (NAFLD) progression in the Alaska Native/ American Indian population (AN/AI) with and without elevated liver function tests. Two research questions guided the study: Do outcomes (abnormal/normal) of LFTs, A1C, lipids, BMI, and inflammatory markers predict or have a relationship with NAFLD progression? Does NAFLD surveillance have a relationship with the patient's outcome as measured by the NAFLD Fibrosis score and FibroScan CAP Score? The theoretical approaches to this study were the transtheoretical model and the health belief model. A quantitative correlational design was used, requiring a minimum sample size of at least 92 participants. Secondary data were obtained from the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program database. The inclusion criteria of the study were AN/AI patients with NAFLD. The results of the study indicated that ALT, AST, and Steatohepatitis were significant predictors of NAFLD Fibrosis score. An increase in A1C, triglycerides, and BMI corresponded with an increase in CAP Scores, while an abnormal AST level corresponded to a decrease in CAP Scores. Plasma ALT evaluation resulted in a decrease in NALFD incidence rates. Various organizations may adopt these study findings to help them in formulating guidelines that will help them in educating the members of the public on risk factors of NAFLD, as well as advocate for appropriate mechanisms in mitigating them. .
546 $a English
590 $a School code: 0543
650 4 $a Epidemiology. $3 568544
650 4 $a Public health. $3 534748
650 4 $a Medicine. $3 641104
650 4 $a Native American studies. $3 2122730
653 $a Non-alcoholic fatty liver disease
653 $a Alaska Native/ American Indian
653 $a Population
653 $a Fibrosis score
653 $a Steatohepatitis
690 $a 0766
690 $a 0564
690 $a 0740
690 $a 0573
710 2 $a Walden University. $b Public Health. $e degree granting institution. $3 3770586
720 1 $a Mori, Naoyo $e degree supervisor.
720 1 $a Miller, Leah $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12A.
790 $a 0543
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32113731